Drug Name | IUPAC Name | Classification (KD Tripathi) | Drug Application | Receptors | Dosage Form | Route of Administration | Adverse Reactions | Appearance | Solubility | pKa Value | Functional Groups |
---|---|---|---|---|---|---|---|---|---|---|---|
Furosemide | 4-chloro-N-(2-furanyl-methyl)-5-sulfamoylanthranilic acid | Diuretic Subclass: Loop diuretic |
Edema, hypertension | Na+/K+/2Cl- cotransporter in the ascending loop of Henle | Tablet (20 mg, 40 mg, 80 mg) Injection (10 mg/mL) |
Oral, Intravenous | Dehydration, electrolyte imbalance, hypotension | White crystalline powder | Slightly soluble in water | pKa = 3.9 | Sulfonamide, carboxyl |
Hydrochlorothiazide | 6-chloro-1,1-dioxo-1,2-benzothiazine-3-carboxamide | Diuretic Subclass: Thiazide diuretic |
Hypertension, edema | Na+/Cl- cotransporter in the distal convoluted tubule | Tablet (12.5 mg, 25 mg, 50 mg) | Oral | Electrolyte imbalance, dizziness, headache | White crystalline powder | Slightly soluble in water | pKa = 6.7 | Thiazide, sulfonamide |
Spironolactone | 17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid lactone | Diuretic Subclass: Potassium-sparing diuretic |
Edema, hypertension | Mineralocorticoid receptor | Tablet (25 mg, 50 mg, 100 mg) | Oral | Hyperkalemia, gynecomastia, menstrual irregularities | White crystalline powder | Slightly soluble in water | pKa = 9.0 | Steroid, lactone |
Acetazolamide | 5-sulfonyl-1,3,4-thiadiazole | Diuretic Subclass: Carbonic anhydrase inhibitor |
Glaucoma, altitude sickness, edema | Carbonic anhydrase enzyme | Tablet (250 mg, 500 mg) Injection (500 mg/mL) |
Oral, Intravenous | Metabolic acidosis, rash, gastrointestinal disturbances | White crystalline powder | Freely soluble in water | pKa = 7.8 | Thiadiazole, sulfonamide |
Manitol | 2,3,4,5,6-pentahydroxyhexane | Osmotic Diuretic Subclass: Osmotic diuretic |
Intracranial pressure reduction, acute kidney injury | Not specific; works by increasing osmotic pressure | Injection (10%, 20% solutions) | Intravenous | Electrolyte imbalance, dehydration, nausea | White crystalline powder | Freely soluble in water | pKa not applicable | Alcohol, hydroxyl |
Amiloride | 2,4-diamino-6-methylpyrimidine-5-carboxylic acid | Diuretic Subclass: Potassium-sparing diuretic |
Hypertension, edema | Epithelium sodium channels | Tablet (5 mg, 10 mg) | Oral | Hyperkalemia, gastrointestinal disturbances | White crystalline powder | Slightly soluble in water | pKa = 9.2 | Pyrimidine, amine |
Torasemide | 3-[(3-methylphenyl)sulfonyl]-4-phenyl-2(3H)-pyridazinone | Diuretic Subclass: Loop diuretic |
Edema, hypertension | Na+/K+/2Cl- cotransporter | Tablet (5 mg, 10 mg, 20 mg) | Oral | Dehydration, hypotension, dizziness | White to off-white powder | Freely soluble in water | pKa = 4.3 | Pyridazine, sulfonamide |
Chlorthalidone | 2-chloro-5-(1-hydroxy-2-methylpropyl)benzenesulfonamide | Diuretic Subclass: Thiazide-like diuretic |
Hypertension, edema | Na+/Cl- cotransporter | Tablet (25 mg, 50 mg) | Oral | Electrolyte imbalance, dizziness | White crystalline powder | Soluble in water | pKa = 6.4 | Thiazide, sulfonamide |
Quinapril | (2S,4S)-1-[(2S)-2-[[[1-(ethoxycarbonyl)-3-phenylpropyl]carbonyl]amino]-(1S)-3-methylbutyl]-(1S)-2-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-4-methyl-2-oxobutanoic acid | Antihypertensive Subclass: ACE inhibitor |
Hypertension, heart failure | Angiotensin-converting enzyme | Tablet (5 mg, 10 mg, 20 mg) | Oral | Cough, dizziness | White to off-white powder | Slightly soluble in water | pKa = 4.0 | Carboxylic acid, amine |
Benazepril | 2-[[[2-(1-ethoxycarbonyl)-3-phenylpropyl]carbonyl]amino]-(1S)-3-methylbutyl]-(1S)-2-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-4-methyl-2-oxobutanoic acid | Antihypertensive Subclass: ACE inhibitor |
Hypertension, heart failure | Angiotensin-converting enzyme | Tablet (5 mg, 10 mg, 20 mg) | Oral | Cough, hyperkalemia | White crystalline powder | Slightly soluble in water | pKa = 4.0 | Carboxylic acid, amine |
Lisinopril | (S)-1-(Ethoxycarbonyl)-L-proline | Antihypertensive Subclass: ACE inhibitor |
Hypertension, heart failure | Angiotensin-converting enzyme | Tablet (5 mg, 10 mg, 20 mg) | Oral | Dizziness, headache | White crystalline powder | Soluble in water | pKa = 4.3 | Carboxylic acid, amine |
Ethacrynic Acid | (E)-3-(2-methylphenyl)-2-[(2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-yl)carbonyl]propanoic acid | Diuretic Subclass: Loop diuretic |
Edema, hypertension | Na+/K+/2Cl- cotransporter | Tablet (25 mg) | Oral | Nausea, vomiting | White crystalline powder | Slightly soluble in water | pKa = 3.0 | Carboxylic acid |
Probenecid | 4-(dipropylsulfamoyl)benzoic acid | Uricosuric Subclass: Uricosuric agent |
Gout | Renal tubules | Tablet (500 mg) | Oral | Headache, nausea | White crystalline powder | Freely soluble in water | pKa = 4.5 | Carboxylic acid, sulfonamide |
Sodium Bicarbonate | Sodium hydrogen carbonate | Alkalinizing agent Subclass: Antacid |
Metabolic acidosis, urinary alkalinization | Not specific | Tablet (325 mg) | Oral | Flatulence, abdominal discomfort | White crystalline powder | Soluble in water | pKa = 6.3 | Salt, bicarbonate |
Potassium Chloride | Potassium chloride | Electrolyte supplement Subclass: Electrolyte |
Hypokalemia | Not specific | Tablet (10 mEq) | Oral | Nausea, diarrhea | White crystalline powder | Soluble in water | Not applicable | Salt, chloride |
Fenoldopam | (R)-1-(2-((1-(2-((1-(1H-indol-3-yl)ethyl)amino)carbonyl)-3-methylbutyl)thio)-1,2,3,4-tetrahydroquinolin-6-yl)-3,4-dihydro-2(1H)-quinolinone | Vasodilator Subclass: Dopamine agonist |
Hypertensive emergencies | Dopamine receptors | Injection (0.1 mg/mL) | Intravenous | Hypotension, tachycardia | Colorless to pale yellow solution | Freely soluble in water | pKa = 7.0 | Indole, amine |
Vasopressin | 1-deamino-8-D-arginine vasopressin | Hormone Subclass: Antidiuretic hormone |
Diabetes insipidus | Vasopressin receptors | Injection (20 units/mL) | Intravenous, subcutaneous | Water retention, headache | Clear colorless solution | Soluble in water | pKa not applicable | Peptide |
Desmopressin | 1-desamino-8-D-arginine vasopressin | Hormone Subclass: Antidiuretic hormone |
Diabetes insipidus | Vasopressin receptors | Tablet (0.1 mg, 0.2 mg) | Oral, intranasal | Headache, nausea | White powder | Freely soluble in water | pKa not applicable | Peptide |
Fexofenadine | 2-[4-[(2-[(4-hydroxyphenyl)phenylmethyl]piperidin-1-yl)methyl]phenyl]propyl]-2-methylpropanoic acid | Antihistamine Subclass: H1 antagonist |
Allergic rhinitis, chronic urticaria | Histamine H1 receptor | Tablet (30 mg, 60 mg, 180 mg) | Oral | Headache, dizziness | White crystalline powder | Slightly soluble in water | pKa = 5.4 | Carboxylic acid, amine |
Thiazide | 2-(2-methyl-3-sulfamoylphenyl)-4H-1,2,4-benzothiadiazine-7-sulfonamide | Diuretic Subclass: Thiazide diuretic |
Hypertension, edema | Na+/Cl- cotransporter | Tablet (12.5 mg, 25 mg) | Oral | Electrolyte imbalance, dizziness | White crystalline powder | Freely soluble in water | pKa = 6.7 | Thiazide, sulfonamide |
Metolazone | 2-[(2-methyl-1,2-benzothiazol-5-yl)methylthio]-4-(2-methyl-4H-1,2,4-benzothiadiazine-7-sulfonyl)-3-sulfamoyl-1,2-benzothiazole | Diuretic Subclass: Thiazide-like diuretic |
Hypertension, edema | Na+/Cl- cotransporter | Tablet (2.5 mg, 5 mg) | Oral | Electrolyte imbalance, dizziness | White crystalline powder | Soluble in water | pKa = 7.3 | Thiazide, sulfonamide |